City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
și încă 2

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT05372614

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of California San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Medical Center, Los Angeles

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT06234605

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of California - Los Angeles, Los Angeles

În curs de recrutareFaza 1

Vârste de 19 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06586957

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

University of California Irvine, Orange
Stanford, Palo Alto
University of California San Francisco, San Francisco

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT05287945

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06625775

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 9, La Jolla
ALX Center 11, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07085091

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
UCLA Santa Monica Hematology Oncology, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Cedars-Sinai Medical Center, Beverly Hills
Norris Comprehensive Cancer Center, Los Angeles
Stanford Cancer Center, Palo Alto
și încă 2

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

UCSF at Berkeley Outpatient Center, Berkeley
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
UCSD Medical Center - Encinitas, Encinitas
și încă 21

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07277413

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Children's Hospital Los Angeles, Los Angeles
University of California at Los Angeles, Los Angeles

În curs de recrutareFaza 1/2

Până la vârsta de 25 · Toate sexele · Actualizat 25 sept. 2026 · NCT04094610

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Oncura Health - Anaheim, Anaheim
Memorial Care Orange Coast Medical Center Attn, Fountain Valley
MemorialCare Orange Coast Medical Center, Fountain Valley
și încă 20

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07222566

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

UC San Diego Medical Center - Encinitas, Encinitas
Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health - Irvine, Irvine
și încă 14

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06989437

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Fountain Valley
Research Site, Glendale
Research Site, Sacramento

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope, Duarte
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07007559

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

UCI Medical Center, Orange
Stanford Medicine, Palo Alto
UC Davis Comprehensive Cancer Center, Sacramento

În curs de recrutareFaza 1/2

Vârste de 12 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT05118789

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT07229313

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles
UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Scripps Clinic Torrey Pines - La Jolla, San Diego
și încă 1

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07339176

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

USC Norris Comprehensive Cancer Center, Los Angeles
UCSF Medical Center at Mount Zion, San Francisco
Stanford Cancer Institute, Stanford

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT06915753

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
TRIO-US (Translational Research in Oncology-US), Los Angeles
UCLA Hematology/Oncology - Santa Monica, Los Angeles
și încă 4

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07218380

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Pacific Cancer Care, Monterey
Torrance Memorial Physician Network-Cancer Care, Torrance
John Muir Health, Walnut Creek

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07028489

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Community Cancer Institute, Clovis
City of Hope, Duarte
Epic Care - Emeryville, Emeryville
și încă 19

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

California Research Institute (CRI), Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07262619

SLV-154 Treatment of Advanced Cancers

Hoag Memorial Hospital Presbyterian, Newport Beach

În curs de recrutareFaza 1

Vârste de 12 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06771219

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
City of Hope, Duarte, Duarte
City of Hope Lennar, Irvine
și încă 6

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07213804

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Hoag Memorial Hospital Presbyterian, Newport Beach

În curs de recrutareFaza 1

Vârste de la 18 la 99 · Toate sexele · Actualizat 21 sept. 2026 · NCT07403721

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
City of Hope Investigational Drug Services (IDS), Duarte
UC San Diego Medical Center - Encinitas, Encinitas
și încă 13

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT07227415

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

UCLA Hematology & Oncology ( Site 0003), Los Angeles
University of California-Irvine Medical Center ( Site 0016), Orange
UCSF Medical Center at Mission Bay ( Site 0034), San Francisco

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT06863272

CREO - Microwave Ablation Feasibility Study

Cedars Sinai, Los Angeles

În curs de recrutare

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07817147

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

The University of California Davis Comprehensive Cancer Center, Sacramento

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT06389123

A Study of KK2269 in Adult Participants With Solid Tumors

City Of Hope National Medical Center, Duarte
Hoag Memorial Hospital Presbyterian, Newport Beach

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 10 sept. 2026 · NCT06266299

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 10 sept. 2026 · NCT07335497

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

Stanford University, Palo Alto

În curs de recrutareFaza 2

Vârste de 12 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07594431

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.